company background image
DBV logo

DBV Technologies ENXTPA:DBV Stock Report

Last Price

€0.90

Market Cap

€92.3m

7D

-2.2%

1Y

-47.2%

Updated

20 Jan, 2025

Data

Company Financials +

DBV Technologies S.A.

ENXTPA:DBV Stock Report

Market Cap: €92.3m

DBV Stock Overview

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. More details

DBV fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Revenue is forecast to grow 60.86% per year

Risk Analysis

Has less than 1 year of cash runway

Highly volatile share price over the past 3 months compared to the French market

Does not have a meaningful market cap (€92M)

Currently unprofitable and not forecast to become profitable over the next 3 years


My Notes

Capture your thoughts, links and company narrative

DBV Technologies S.A. Competitors

MaaT Pharma

ENXTPA:MAAT

€111.8m

Inventiva

ENXTPA:IVA

€185.0m

OSE Immunotherapeutics

ENXTPA:OSE

€146.3m

ABIONYX Pharma

ENXTPA:ABNX

€46.1m

Price History & Performance

Summary of share price highs, lows and changes for DBV Technologies
Historical stock prices
Current Share Price€0.90
52 Week High€1.83
52 Week Low€0.51
Beta0.80
1 Month Change52.54%
3 Month Change24.48%
1 Year Change-47.15%
3 Year Change-65.52%
5 Year Change-95.55%
Change since IPO-89.98%

Recent News & Updates

Revenues Not Telling The Story For DBV Technologies S.A. (EPA:DBV) After Shares Rise 76%

Jan 10
Revenues Not Telling The Story For DBV Technologies S.A. (EPA:DBV) After Shares Rise 76%

DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up

Oct 24
DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up

Recent updates

Revenues Not Telling The Story For DBV Technologies S.A. (EPA:DBV) After Shares Rise 76%

Jan 10
Revenues Not Telling The Story For DBV Technologies S.A. (EPA:DBV) After Shares Rise 76%

DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up

Oct 24
DBV Technologies S.A.'s (EPA:DBV) 41% Share Price Surge Not Quite Adding Up

Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts

Aug 04
Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts

Risks To Shareholder Returns Are Elevated At These Prices For DBV Technologies S.A. (EPA:DBV)

Jun 14
Risks To Shareholder Returns Are Elevated At These Prices For DBV Technologies S.A. (EPA:DBV)

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For DBV Technologies S.A.'s (EPA:DBV) CEO For Now

DBV Technologies S.A. (EPA:DBV) Released Earnings Last Week And Analysts Lifted Their Price Target To €6.50

May 09
DBV Technologies S.A. (EPA:DBV) Released Earnings Last Week And Analysts Lifted Their Price Target To €6.50

Some DBV Technologies S.A. (EPA:DBV) Analysts Just Made A Major Cut To Next Year's Estimates

Mar 14
Some DBV Technologies S.A. (EPA:DBV) Analysts Just Made A Major Cut To Next Year's Estimates

DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price

Mar 10
DBV Technologies S.A. (EPA:DBV) Just Reported Earnings, And Analysts Cut Their Target Price

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

Dec 01
Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

Jun 23
Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?

We're Hopeful That DBV Technologies (EPA:DBV) Will Use Its Cash Wisely

Mar 09
We're Hopeful That DBV Technologies (EPA:DBV) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About DBV Technologies' (EPA:DBV) Cash Burn Situation

Oct 04
Here's Why We're Not Too Worried About DBV Technologies' (EPA:DBV) Cash Burn Situation

DBV Technologies S.A. (EPA:DBV) Shares Could Be 45% Below Their Intrinsic Value Estimate

Aug 06
DBV Technologies S.A. (EPA:DBV) Shares Could Be 45% Below Their Intrinsic Value Estimate

Here's Why DBV Technologies (EPA:DBV) Must Use Its Cash Wisely

Mar 14
Here's Why DBV Technologies (EPA:DBV) Must Use Its Cash Wisely

Shareholder Returns

DBVFR BiotechsFR Market
7D-2.2%-3.0%4.1%
1Y-47.2%-27.9%3.7%

Return vs Industry: DBV underperformed the French Biotechs industry which returned -27.1% over the past year.

Return vs Market: DBV underperformed the French Market which returned 4.3% over the past year.

Price Volatility

Is DBV's price volatile compared to industry and market?
DBV volatility
DBV Average Weekly Movement23.0%
Biotechs Industry Average Movement7.2%
Market Average Movement4.5%
10% most volatile stocks in FR Market9.3%
10% least volatile stocks in FR Market2.4%

Stable Share Price: DBV's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: DBV's weekly volatility has increased from 13% to 23% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2002108Daniel Tasséwww.dbv-technologies.com

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis. The company’s earlier stage research programs includes vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes.

DBV Technologies S.A. Fundamentals Summary

How do DBV Technologies's earnings and revenue compare to its market cap?
DBV fundamental statistics
Market cap€92.30m
Earnings (TTM)-€99.34m
Revenue (TTM)€12.18m

7.6x

P/S Ratio

-0.9x

P/E Ratio

Is DBV overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DBV income statement (TTM)
RevenueUS$12.52m
Cost of RevenueUS$0
Gross ProfitUS$12.52m
Other ExpensesUS$114.60m
Earnings-US$102.09m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.00
Gross Margin100.00%
Net Profit Margin-815.73%
Debt/Equity Ratio0%

How did DBV perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 11:57
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DBV Technologies S.A. is covered by 18 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tazeen AhmadBofA Global Research
Jean-Jacques Le FurBryan Garnier & Co
Andrew PetersDeutsche Bank